SKI Market

Indian Indices

Nifty

26,215.55 10.25
(0.04%)

Sensex

85,720.38 110.87
( 0.13%)

Bank Nifty

59,737.30 209.25
( 0.35%)

Nifty IT

37,446.30 81.70
( 0.22%)

Global Indices

Nasdaq

47,439.25 305.79
(0.65%)

Dow Jones

6,833.01 46.13
(0.68%)

Hang Seng

50,154.28 595.21
(1.20%)

Nikkei 225

9,688.31 -3.27
(-0.03%)

Forex

USD-INR

89.15 -0.06
(-0.06%)

EUR-INR

102.93 0.12
(0.12%)

GBP-INR

117.17 0.31
(0.26%)

JPY-INR

0.57 0.00
(0.22%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

32.9918134

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

35.95

8666.76

EPS(TTM)

Face Value()

Div & Yield %

5.32

0.42

Back

ushdev international ltd

Ganesh Infraworld standalone net profit rises 156.66% in the September 2025 quarter

Nov 15,2025

Net profit of Ganesh Infraworld rose 156.66% to Rs 18.12 crore in the quarter ended September 2025 as against Rs 7.06 crore during the previous quarter ended September 2024. Sales rose 120.95% to Rs 209.97 crore in the quarter ended September 2025 as against Rs 95.03 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	209.97	95.03	121
OPM %	12.25	9.98	-
PBDT	25.07	9.42	166
PBT	24.21	9.09	166
NP	18.12	7.06	157

26,215.55 10.25 (0.04%)

85,720.38 110.87 ( 0.13%)

59,737.30 209.25 ( 0.35%)

37,446.30 81.70 ( 0.22%)

47,439.25 305.79 (0.65%)

6,833.01 46.13 (0.68%)

50,154.28 595.21 (1.20%)

9,688.31 -3.27 (-0.03%)

89.15 -0.06 (-0.06%)

102.93 0.12 (0.12%)

117.17 0.31 (0.26%)

0.57 0.00 (0.22%)